Conditions: Diarrhea
Keywords: TD traveller's diarrhea campylobacter shigella salmonella E. coli diarrhea
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 210
Healthy volunteers: yes

Brief summary:
The purpose of this study is to determine if 600 mg of rifaximin, taken once a day for 14 days by healthy subjects, is safe and effective for the prevention of travellers' diarrhea compared to placebo.

Detailed description:
To determine if 600 mg of rifaximin, taken once a day for 14 days by healthy subjects, is safe and effective for the prevention of travellers' diarrhea compared to placebo.

Arms:
arm 1: Rifaximin arm 2: Placebo

Interventions: intervention 1: Rifaximin intervention 2: Placebo
Intervention descriptions: intervention 1: None intervention 2: None

Protocol document: